HeartBeam Inc.'s New U.S. Patents: Enhancing Cardiac Diagnostics

What are the two new U.S. patents issued to HeartBeam Inc.?

The first patent protects a credit card–sized, cable-free 3D ECG device that captures high-fidelity electrical signals from three noncoplanar directions, and the second covers a rhythm analysis algorithm that continuously analyzes signal input.

Why are these patents significant for HeartBeam Inc.?

These patents enhance HeartBeam’s intellectual property portfolio, strengthen its position in cardiac monitoring technology, and mark a strategic advancement in its proprietary technology.

How does the credit card–sized 3D ECG device work?

The device captures high-fidelity electrical signals from chest and finger electrodes in three noncoplanar directions, offering a portable solution for cardiac diagnostics.

What does the rhythm analysis algorithm do?

The algorithm continuously analyzes signal input to provide insights into heart health, enhancing the diagnostic capabilities of HeartBeam’s technology.

How many patents does HeartBeam Inc. now hold?

HeartBeam now holds more than 20 U.S. and international patents, with additional applications pending.

Where can I find more information about HeartBeam Inc.’s latest developments?

The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT.

What is the focus of HeartBeam Inc.’s technology?

HeartBeam focuses on delivering powerful, personalized insights into heart health through its innovative 3D ECG platform.

Who is the target audience for HeartBeam Inc.’s technology?

The target audience includes healthcare providers and patients seeking advanced cardiac monitoring and diagnostic solutions.